TrialInternational journal of nanomedicine2022

Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer.

Yoshimasa Kosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.